Physician profile
Christopher C Pickett
NPI 1386752210
$5,482.58
in general payments reported to CMS, 2019-2025
12 companies · $2,350 in 2025
The $2,350 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,386 · 2020: $67.90 · 2021: $258 · 2022: $70.63 · 2023: $256 · 2024: $1,094 · 2025: $2,350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,294 · Food and Beverage: $1,406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,294.30 |
| Food and Beverage | $1,406.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,559.47 | 2019-2025 | Aveir, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Medtronic, INC. | $373.53 | 2022-2025 | Affera Mapping System, Azure Xt Dr Mri Surescan, Micra |
| Pfizer INC. | $95.98 | 2019-2024 | |
| Abiomed | $94.08 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $78.78 | 2021-2025 | Lifevest |
| Medtronic Vascular, INC. | $76.53 | 2019-2020 | |
| Amgen INC. | $58.46 | 2019 | |
| Novartis Pharmaceuticals Corporation | $42.50 | 2024-2025 | |
| Irhythm Technologies, INC. | $35.52 | 2023 | Zio Xt Patch |
| E.R. Squibb & Sons, L.L.C. | $25.84 | 2025 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.10 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.79 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Pickett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.